Genetic Analysis AS announces the outcome of the warrant exercise

Oslo, Norway, November 21, 2022 – On November 16, 2022the exercise period for Genetic Analysis AS’s (“GA” or the “Company”) warrants of series TO 1, issued in connection with the Company’s IPO of units in September/October 2021, ended. No warrants of series TO 1 have been exercised. The reason for this is deemed to be that the subscription price for the exercise of warrants of series TO 1 has exceeded the current share price during the entire exercise period.

During the period November 2 until November 16, 2022holders of warrants of series TO 1 were, for each warrant, entitled to subscribe for one (1) new share in GA, at a subscription price set to NOK 9.30 per share. No warrants have been exercised, and therefore, the share capital and the number of shares in the Company remain unchanged.

For more information about warrants of series TO 1, please contact:Eilert ReceivedCFO
Email: ea@genetic-analysis.com

Website: www.genetic-analysis.com

For more information about GA, please contact:Ronny HermansenCEO
Email: rh@genetic-analysis.com

About Genetic Analysis:
Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map® platform is based on a pre-determined multiplex targets approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to helping unlock and restore the human microbiome through its state-of-the-art technology. GA employs a team of highly qualified employees with scientific backgrounds and competence in bioinformatics, molecular biology, and bioengineering. www.genetic-analysis.com

Interested in reading more about GA’s products? Please visit ga-map.com

https://news.cision.com/genetic-analysis-as/r/genetic-analysis-as-announces-the-outcome-of-the-warrant-exercise,c3668938

https://mb.cision.com/Main/20846/3668938/1678910.pdf

(c) 2022 Severance. All rights reserved., source Press Releases – English

.

Leave a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: